Major adverse limb events in type 2 diabetes patients receiving glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: A retrospective multi-institutional study
Fu‐Chih Hsiao, Chia‐Pin Lin, Ying‐Chang Tung, Chia-Tung Wu, Pao‐Hsien Chu
Topics & Concepts
MedicineType 2 diabetesDiabetes mellitusInternal medicineAdverse effectEndocrinologyCotransporterGlucagon-like peptide-1GlucagonSodiumPharmacologyInsulinOrganic chemistryChemistryDiabetes Treatment and ManagementBariatric Surgery and OutcomesDiabetes, Cardiovascular Risks, and Lipoproteins